BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21254017)

  • 61. Impact of preoperative targeted therapy on postoperative complications after resection of colorectal liver metastases.
    Neeff HP; Drognitz O; Klock A; Illerhaus G; Opitz OG; Hopt UT; Makowiec F
    Int J Colorectal Dis; 2012 May; 27(5):635-45. PubMed ID: 22139030
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.
    Chun YS; Vauthey JN; Boonsirikamchai P; Maru DM; Kopetz S; Palavecino M; Curley SA; Abdalla EK; Kaur H; Charnsangavej C; Loyer EM
    JAMA; 2009 Dec; 302(21):2338-44. PubMed ID: 19952320
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases.
    Li DB; Ye F; Wu XR; Wu LP; Chen JX; Li B; Zhou YM
    World J Gastroenterol; 2013 Feb; 19(5):761-8. PubMed ID: 23431050
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bevacizumab with preoperative chemotherapy versus preoperative chemotherapy alone for colorectal cancer liver metastases: a retrospective cohort study.
    Lu ZH; Peng JH; Wang FL; Yuan YF; Jiang W; Li YH; Wu XJ; Chen G; Ding PR; Li LR; Kong LH; Lin JZ; Zhang RX; Wan DS; Pan ZZ
    Medicine (Baltimore); 2016 Aug; 95(35):e4767. PubMed ID: 27583930
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Liver failure in patients treated with chemotherapy for colorectal liver metastases: Role of chronic disease scores in patients undergoing major liver surgery. A case-matched analysis.
    Ratti F; Cipriani F; Catena M; Paganelli M; Aldrighetti L
    Eur J Surg Oncol; 2014 Nov; 40(11):1550-6. PubMed ID: 25085794
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Delayed bile leak with avastin after liver resection for metastatic colorectal cancer.
    Lordan JT; Wilkins M; Karanjia ND
    Hepatogastroenterology; 2011; 58(110-111):1769-70. PubMed ID: 22086700
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases.
    Volk AM; Fritzmann J; Reissfelder C; Weber GF; Weitz J; Rahbari NN
    BMC Cancer; 2016 Feb; 16():84. PubMed ID: 26864935
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Retrospective analysis of pathological response in colorectal cancer liver metastases following treatment with bevacizumab.
    Vera R; Gomez Dorronsoro M; Lopez-Ben S; Viudez A; Queralt B; Hernandez I; Ortiz-Duran MR; Zazpe C; Soriano J; Amat I; Herrera Cabezón J; Diaz E; Codina-Barreras A; Hernandez-Yagüe X; Quera A; Figueras J
    Clin Transl Oncol; 2014 Aug; 16(8):739-45. PubMed ID: 24338508
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation.
    Starlinger P; Alidzanovic L; Schauer D; Maier T; Nemeth C; Perisanidis B; Tamandl D; Gruenberger B; Gruenberger T; Brostjan C
    Br J Cancer; 2012 Sep; 107(6):961-6. PubMed ID: 22850548
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bevacizumab and postoperative complications after hepatic surgery for colorectal metastases.
    Petrelli NJ
    J Clin Oncol; 2009 Apr; 27(11):1917; author reply 1918. PubMed ID: 19255304
    [No Abstract]   [Full Text] [Related]  

  • 71. Biochemical liver function test parameter levels in relation to treatment response in liver metastatic colorectal patients treated with FOLFOX4 with or without bevacizumab.
    Denić K; Tarabar D; Obradovic S; Ristić M; Spasić J; Radosavljević D; Ugrešić N
    Srp Arh Celok Lek; 2016; 144(11-12):615-20. PubMed ID: 29659222
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safety of bevacizumab in mild haemophilia B.
    Lambert C; Deneys V; Pothen D; Hermans C
    Thromb Haemost; 2008 May; 99(5):963-4. PubMed ID: 18449429
    [No Abstract]   [Full Text] [Related]  

  • 73. [A case of unresectable multiple liver metastases of colorectal cancer in which ALTA(ZION), used to control internal hemorrhoidal bleeding, enabled administration of bevacizumab].
    Kato K; Otsuka K; Kato N; Itabashi T; Akiyama Y; Wakabayashi G
    Gan To Kagaku Ryoho; 2013 Nov; 40(11):1553-5. PubMed ID: 24231714
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria.
    Chung WS; Park MS; Shin SJ; Baek SE; Kim YE; Choi JY; Kim MJ
    AJR Am J Roentgenol; 2012 Oct; 199(4):809-15. PubMed ID: 22997372
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Perioperative risks of bevacizumab and other biologic agents for hepatectomy: theoretical or evidence based?
    Bilchik AJ; Hecht JR
    J Clin Oncol; 2008 Apr; 26(11):1786-8. PubMed ID: 18398144
    [No Abstract]   [Full Text] [Related]  

  • 76. Effect of Adding Bevacizumab to Chemotherapy on Pathologic Response to Preoperative Systemic Therapy for Resectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
    Jácome AA; Oliveira FA; Lino F; Lima JPSN
    Clin Colorectal Cancer; 2021 Sep; 20(3):265-272. PubMed ID: 34158251
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Body composition and outcome in patients undergoing resection of colorectal liver metastases.
    van Vledder MG; Levolger S; Ayez N; Verhoef C; Tran TC; Ijzermans JN
    Br J Surg; 2012 Apr; 99(4):550-7. PubMed ID: 22246799
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bevacizumab and postoperative wound complications in patients with liver metastases of colorectal cancer.
    Utsumi H; Honma Y; Nagashima K; Iwasa S; Takashima A; Kato K; Hamaguchi T; Yamada Y; Shimada Y; Kishi Y; Nara S; Esaki M; Shimada K
    Anticancer Res; 2015 Apr; 35(4):2255-61. PubMed ID: 25862887
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Variation in referral practice for patients with colorectal cancer liver metastases.
    Young AL; Adair R; Culverwell A; Guthrie JA; Botterill ID; Toogood GJ; Lodge JP; Prasad KR
    Br J Surg; 2013 Nov; 100(12):1627-32. PubMed ID: 24264786
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Selection for hepatic resection of colorectal liver metastases: expert consensus statement.
    Adams RB; Aloia TA; Loyer E; Pawlik TM; Taouli B; Vauthey JN; ; ;
    HPB (Oxford); 2013 Feb; 15(2):91-103. PubMed ID: 23297719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.